Cytovale, based in San Francisco, Calif., is a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, and applying this first to sepsis, a condition whose early detection dramatically improves patient outcomes.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/30/19	$7,400,000	Series B Extension	Blackhorn Ventures Breakout Ventures Western Technology Investment	undisclosed